Bontac Bio-Engineering (Shenzhen) Co., Ltd.

E3F46
China Mainland
Company Profile
  • Year Established: 2012
  • Total Assets(USD): 500,000 to 99,999,999
  • Total Number of Staff: 100-500
  • Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Reputation,Quality Service
  • Business Type: Trading Company,Manufacturer
  • R&D Capacity: Own Brand
  • Annual Turnover(USD) : 500,000 to 99,999,999
  • Main Sales Markets : North America,Western Europe,Eastern Europe,Australasia,Asia

Founded in July 2012, Bontac Bio-Engineering (Shenzhen) Co., Ltd. (hereafter referred to as BONTAC) is a high-tech enterprise integrating R&D, production and sales, with enzyme catalysis as the core biosynthetic technology. There are six major series of products in BONTAC, involving coenzymes, natural products, sugar substitutes, cosmetics, dietary supplements and medical intermediates. As the leader of the global NMN industry, BONTAC has the first whole-enzyme catalysis technology in China. Our coenzyme products are widely used in health industry, medical & beauty, green agriculture, biomedicine and other fields. BONTAC adheres to independent innovation, with more than 170 invention patents. BONTAC has undertaken lots of government key technology projects at provincial and municipal level. What’s more, BONTAC has established the first coenzyme engineering technology research center at the provincial level in China which also is the sole in Guangdong Province. BONTAC will focus on its advantages of green, low-carbon and high-value-added biosynthesis technology, and build ecological relationship with academia as well as upstream/downstream partners, continuously leading the synthetic biological industry and creating a better life for human beings.

Year Established: 2012

Total Assets(USD): 500,000 to 99,999,999

Total Number of Staff: 100-500

Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Reputation,Quality Service

Business Type: Trading Company,Manufacturer

R&D Capacity: Own Brand

Annual Turnover(USD) : 500,000 to 99,999,999

Main Sales Markets : North America,Western Europe,Eastern Europe,Australasia,Asia

Top Products
Copyright 2006-2022 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
Powered by